Ken Fisher's position in Astrazeneca plc is currently worth $738 Million. That's 0.31% of their equity portfolio (75th largest holding). The first Astrazeneca plc trade was made in Q3 2015. Since then Ken Fisher bought shares 33 more times and sold shares on four occasions. The stake costed the investor $467 Million, netting the investor a gain of 58% so far.